Search hospitals > New York > New York
Mount Sinai Hospital
Claim this profileNew York, New York 10029
Global Leader in Parotid Gland Cancer
Global Leader in Cancer
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Breast Cancer
Conducts research for Stroke
681 reported clinical trials
132 medical researchers
Summary
Mount Sinai Hospital is a medical facility located in New York, New York. This center is recognized for care of Parotid Gland Cancer, Cancer, Adult T-Cell Leukemia/Lymphoma, Breast Cancer, Stroke and other specialties. Mount Sinai Hospital is involved with conducting 681 clinical trials across 1,070 conditions. There are 132 research doctors associated with this hospital, such as Pillai Pallavi Madhusoodhan, Gary D. Crouch, Deborah Doroshow, MD, PhD, and Matthew Galsky, M.D..Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Pillai Pallavi MadhusoodhanMount Sinai Hospital5 years of reported clinical research
Studies Adult T-Cell Leukemia/Lymphoma
Studies Cancer
17 reported clinical trials
51 drugs studied
Gary D. CrouchMount Sinai Hospital5 years of reported clinical research
Studies Cancer
Studies Adult T-Cell Leukemia/Lymphoma
17 reported clinical trials
63 drugs studied
Deborah Doroshow, MD, PhDMount Sinai Hospital4 years of reported clinical research
Studies Cancer
Studies Solid Tumors
17 reported clinical trials
41 drugs studied
Matthew Galsky, M.D.Icahn School of Medicine at Mount Sinai5 years of reported clinical research
Studies Bladder Cancer
Studies Cancer
16 reported clinical trials
29 drugs studied
Clinical Trials running at Mount Sinai Hospital
Breast Cancer
Bladder Cancer
Parotid Gland Cancer
Colorectal Cancer
Testicular cancer
Rectal Cancer
Pancreatic Cancer
Epilepsy
Atrial Fibrillation
Cancer
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mount Sinai Hospital?
Where is Mount Sinai Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Mount Sinai Hospital accept?
What awards or recognition has Mount Sinai Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.